IDESPHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IDESPHARMA
Largest movements
- Receivables within one year -€70,191
down €70,191 (-47.9%), from €146,647 to €76,456
of which Trade receivables: -€42,063
- Financial fixed assets +€65,229
up €65,229 (+7.9%), from €822,341 to €887,569
- Cash +€35,041
up €35,041 (+139.3%), from €25,147 to €60,187
mainly Receivables within one year (+€70,191) and Debts after one year (+€38,337)
- Tangible fixed assets -€31,711
down €31,711 (-23.4%), from €135,447 to €103,737
of which Furniture and vehicles: -€26,413
- Stocks and contracts -€24,535
down €24,535 (-10.4%), from €234,859 to €210,324
- Trade debts -€55,106
down €55,106 (-53.5%), from €102,948 to €47,842
- Debts after one year +€38,337
up €38,337 (+4.5%), from €859,353 to €897,690
of which Other amounts payable: +€55,628
- Staff costs +€96,150
up €96,150 (+144.5%), from €66,540 to €162,690
- Gross operating margin -€53,751
down €53,751 (-21.9%), from €245,201 to €191,450
- Taxes -€47,838
down €47,838 (-98.2%), from €48,705 to €866
- Depreciation +€3,466
up €3,466 (+12.3%), from €28,245 to €31,711
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,364,597 | €1,339,972 | -€24,625 | -1.8% |
| Fixed assets | 21/28 | €957,788 | €991,306 | +€33,518 | +3.5% |
| Tangible fixed assets | 22/27 | €135,447 | €103,737 | -€31,711 | -23.4% |
| Plant, machinery and equipment | 23 | €38,319 | €33,021 | -€5,298 | -13.8% |
| Furniture and vehicles | 24 | €97,129 | €70,716 | -€26,413 | -27.2% |
| Financial fixed assets | 28 | €822,341 | €887,569 | +€65,229 | +7.9% |
| Current assets | 29/58 | €406,809 | €348,666 | -€58,143 | -14.3% |
| Stocks and contracts in progress | 3 | €234,859 | €210,324 | -€24,535 | -10.4% |
| Stocks | 30/36 | €234,859 | €210,324 | -€24,535 | -10.4% |
| Amounts receivable within one year | 40/41 | €146,647 | €76,456 | -€70,191 | -47.9% |
| Trade receivables | 40 | €89,270 | €47,207 | -€42,063 | -47.1% |
| Other amounts receivable | 41 | €57,378 | €29,249 | -€28,128 | -49.0% |
| Cash at bank and in hand | 54/58 | €25,147 | €60,187 | +€35,041 | +139.3% |
| Deferred charges and accrued income | 490/1 | €157 | €1,698 | +€1,542 | +984.5% |
| Total equity and liabilities | 10/49 | €1,364,597 | €1,339,972 | -€24,625 | -1.8% |
| Equity | 10/15 | €359,829 | €353,392 | -€6,436 | -1.8% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Reserves | 13 | €354,829 | €354,829 | = | 0.0% |
| Distributable reserves | 133 | €354,829 | €354,829 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | -€6,436 | -€6,436 | |
| Amounts payable | 17/49 | €1,004,768 | €986,579 | -€18,189 | -1.8% |
| Amounts payable after more than one year | 17 | €859,353 | €897,690 | +€38,337 | +4.5% |
| Financial debts | 170/4 | €17,291 | - | -€17,291 | |
| Other amounts payable | 178/9 | €842,062 | €897,690 | +€55,628 | +6.6% |
| Amounts payable within one year | 42/48 | €145,416 | €88,890 | -€56,526 | -38.9% |
| Current portion of amounts payable after more than one year | 42 | €22,229 | €17,291 | -€4,938 | -22.2% |
| Trade debts | 44 | €102,948 | €47,842 | -€55,106 | -53.5% |
| Suppliers | 440/4 | €102,948 | €47,842 | -€55,106 | -53.5% |
| Taxes, remuneration and social security | 45 | €20,239 | €23,757 | +€3,518 | +17.4% |
| Taxes | 450/3 | €10,892 | €3,770 | -€7,122 | -65.4% |
| Remuneration and social security | 454/9 | €9,347 | €19,988 | +€10,640 | +113.8% |
| Remuneration, social security and pensions | 62 | €66,540 | €162,690 | +€96,150 | +144.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €28,245 | €31,711 | +€3,466 | +12.3% |
| Other operating charges | 640/8 | €1,021 | €700 | -€321 | -31.4% |
| Gross operating margin | 9900 | €245,201 | €191,450 | -€53,751 | -21.9% |
| Operating profit (loss) | 9901 | €149,395 | -€3,651 | -€153,046 | |
| Financial charges | 65/66B | €3,424 | €1,919 | -€1,505 | -43.9% |
| Recurring financial charges | 65 | €3,424 | €1,919 | -€1,505 | -43.9% |
| Profit (loss) for the period before taxes | 9903 | €145,971 | -€5,570 | -€151,541 | |
| Income taxes | 67/77 | €48,705 | €866 | -€47,838 | -98.2% |
| Profit (loss) for the period | 9904 | €97,266 | -€6,436 | -€103,703 | |
| Profit (loss) for the period to be appropriated | 9905 | €97,266 | -€6,436 | -€103,703 |
Source: filed annual accounts (NBB), fiscal years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 September 2026 via checked.be.